> top > docs > PMC:7558233 > spans > 40421-41038 > annotations

PMC:7558233 / 40421-41038 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1030 92-102 Species denotes SARS-CoV-2 Tax:2697049
1031 404-414 Species denotes adenovirus Tax:10508
1032 428-438 Species denotes SARS-CoV-2 Tax:2697049
1033 333-341 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T239 0-103 Sentence denotes Vaccine development has benefited from the early release of the complete genome sequence of SARS-CoV-2.
T240 104-273 Sentence denotes As of 3 September 2020, according to the WHO, 33 vaccine candidates are at different stages of clinical development, six of which are at phase III clinical trials [114].
T241 274-383 Sentence denotes On 22 July 2020, China approved the use of two inactivated COVID-19 vaccines developed by Sinovac Biotech Co.
T242 384-395 Sentence denotes Ltd. [115].
T243 396-517 Sentence denotes Another adenovirus vector-based SARS-CoV-2 vaccine was approved by the administrative office of Russia on 10 August 2020.
T244 518-617 Sentence denotes U.S. authorities have recently announced the pending approval of a vaccine by the end of this year.